Related resources
Full-text held externally
- PMID: 19363698
- UKPMCID: 19363698
- DOI: 10.1007/s11568-009-9032-6
Search for item elsewhere
University researcher(s)
Pharmacogenetics education in British medical schools.
Higgs, Jenny E; Andrews, Julie; Gurwitz, David; Payne, Katherine; Newman, William
Genomic medicine. 2008;2(3-4):101-5.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:
Full-text held externally
- PMID: 19363698
- UKPMCID: 19363698
- DOI: 10.1007/s11568-009-9032-6
Abstract
Pharmacogenetic tests allow medications to be tailored to individual patients to improve efficacy and reduce drug toxicity. In 2005, the International Society of Pharmacogenomics (ISP) made recommendations for undergraduate medical teaching in pharmacogenetics. We aimed to establish the quantity and scope of this in British medical schools. An electronic survey was sent to all British medical schools. Nineteen out of 34 (56%) medical schools responded. Sixteen of the 19 (84%) respondents provided pharmacogenetics teaching, usually 1-2 h in total. Only four (21%) medical schools offered the four or more hours of teaching recommended by the ISP. However, 10 of 16 (63%) schools felt the amount of pharmacogenetic teaching offered was sufficient. The quantity of undergraduate teaching of pharmacogenetics is low. However, a majority of UK medical schools teach it, covering a broad scope of elements. It is encouraging that future clinicians are being provided with the knowledge to deliver pharmacogenetics into clinical practice.